MENU
IMNN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Imunon (IMNN) Ownership - Who owns Imunon?

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies... Show more

Profile

Industry
Medical Specialties
Address
997 Lenox Drive
Phone
+1 609 896-9100
Employees
20
Web
https://www.imunon.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.48M
P/E Ratio
N/A
Total Cash
4.79M
Projected Growth
N/A
Total Debt
911.75K
Revenue
N/A
Risk (Beta)
2.14
Dividend Yield
N/A
Total Cash/Share
1.14
Total Debt/Equity
12.33
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
IMNN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company which engages in the provision of oncology drug development services

Industry Biotechnology

Profile
Details
Industry
Medical Specialties
Address
997 Lenox Drive
Phone
+1 609 896-9100
Employees
20
Web
https://www.imunon.com